Occurrence of the Southeast Asian/South American SVMNT Haplotype of the Chloroquine-Resistance Transporter Gene in Plasmodium falciparum in Tanzania

Alifrangis, Michael; Dalgaard, Michael B.; Lusingu, John P.; Vestergaard, Lasse S.; Staalsoe, Trine; Jensen, Anja T. R.; Enevold, Anders; Rønn, Anita M.; Khalil, Insaf F.; Warhurst, David C.; Lemnge, Martha M.; Theander, Thor G.; Bygbjerg, Ib C.
June 2006
Journal of Infectious Diseases;6/15/2006, Vol. 193 Issue 12, p1738
Academic Journal
Two main haplotypes, CVIET and SVMNT, of the Plasmodium falciparum chloroquine-resistance transporter gene (Pfcrt) are linked to 4-aminoquinoline resistance. The CVIET haplotype has been reported in most malaria-endemic regions, whereas the SVMNT haplotype has only been found outside Africa. We investigated Pfcrt haplotype frequencies in Korogwe District, Tanzania, in 2003 and 2004. The SVMNT haplotype was not detected in 2003 but was found in 19% of infected individuals in 2004. Amodiaquine use has increased in the region. The introduction and high prevalence of the SVMNT haplotype may reflect this and may raise concern regarding the use of amodiaquine in artemisinin-based combination therapies in Africa.


Related Articles

  • Therapeutic efficacy of chloroquine and sulfadoxine/pyrimetha-mine against Plasmodium falciparuminfection in Somalia. Warsame, M.; Abdillahi, A.; Duale, O. Nur; Ismail, A. Nur; Hassan, A. M.; Mohamed, A.; Warsame, A. // Bulletin of the World Health Organization;2002, Vol. 80 Issue 9, p704 

    Investigates the efficacy of chloroquine and sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum infections in Somalia. Clinical failure rate of chloroquine treatment; Doubts about the therapeutic life of sulfadoxine/pyrimethamine in relation to malaria due to high...

  • Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali de Radiguès, Xavier; Diallo, Kandian I.; Diallo, Mouctar; Ngwakum, Paul Akisa; Maiga, Hamma; Djimdé, Abdoulaye; Sacko, Massambou; Doumbo, Ogobara; Guthmann, Jean-Paul // Transactions of the Royal Society of Tropical Medicine & Hygiene;Nov2006, Vol. 100 Issue 11, p1013 

    Summary: We report the results of an in vivo antimalarial efficacy study with chloroquine (CQ) and sulfadoxine/pyrimethamine (SP) conducted between 2003 and 2004 in Koumantou, southern Mali. A total of 244 children were included in the study; 210 children were followed-up for 28 days according...

  • Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.  // Malaria Journal;2012, Vol. 11 Issue 1, p92 

    The article focuses on Plasmodium falciparum for its novel genotypes and chloroquine (CQ)-resistance gene pfcrt. In this species, 15 pfcrt genotypes represented by five amino acids have been described from various endemic regions. The study comprised of collection of polymorphic sites at amino...

  • Efficacy of drug prophylaxis. Phillips-Howard, P. A. // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p23 

    With the spread of chloroquine resistant Plasmodium falciparum the control of malaria has become increasingly complex. In recent years, particular concern has arisen over how best to prevent malaria in non-immune international travellers. Prior to the recognition of the potential toxicity of...

  • Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania. Schönfeld, Mirjam; Miranda, Isabel Barreto; Schunk, Mirjam; Maduhu, Ibrahim; Maboko, Leonard; Hoelscher, Michael; Berens-Riha, Nicole; Kitua, Andrew; Löscher, Thomas // Malaria Journal;2007, Vol. 6, p1 

    Background: In Tanzania, drug-resistant malaria parasites are an increasing public health concern. Because of widespread chloroquine (CQ) resistance Tanzania changed its first line treatment recommendations for uncomplicated malaria from CQ to sulfadoxine-pyrimethamine (SP) in 2001. Loss of SP...

  • 3-Aminosterol Compounds as a New Class of Anti-Malarial Agents against Chloroquine-Susceptible and -Resistant Plasmodium falciparum. Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Rogier, Christophe; Letourneux, Yves; Pradines, Bruno; Brunel, Jean Michel // Letters in Drug Design & Discovery;Mar2009, Vol. 6 Issue 2, p163 

    A series of 3-amino- and polyaminosterol analogues of squalamine and trodusquemine were evaluated for their in vitro antimalarial properties against chloroquine-susceptible and -resistant Plasmodium falciparum. These derivatives were designed possessing a good therapeutic index compared to...

  • Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bié provinces, central Angola Guthmann, Jean-Paul; Ampuero, Julia; Fortes, Filomeno; van Overmeir, Chantal; Gaboulaud, Valérie; Tobback, Sophie; Dunand, Jean; Saraiva, Nilton; Gillet, Philippe; Franco, Joan; Denoncin, Anne; van Herp, Michel; Balkan, Suna; Dujardin, Jean Claude; D’Alessandro, Umberto; Legros, Dominique // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jul2005, Vol. 99 Issue 7, p485 

    Summary: We studied three antimalarial treatments in Caala and Kuito, Angola, in 2002 and 2003. We tested chloroquine (CQ), amodiaquine (AQ) and sulfadoxine-pyrimethamine (SP) in Caala, and AQ, SP and the combinations AQ+artesunate (AQ+AS) and SP+artesunate (SP+AS) in Kuito. A total of 619...

  • Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia. Mekonnen, Seleshi Kebede; Medhin, Girmay; Berhe, Nega; Clouse, Ronald M.; Aseffa, Abraham // Malaria Journal;Aug2015, Vol. 14 Issue 1, p1 

    Background: The development and spread of chloroquine-resistant Plasmodium falciparum threatens the health of millions of people and poses a major challenge to the control of malaria. Monitoring drug efficacy in 2-year intervals is an important tool for establishing rational anti-malarial drug...

  • Recent Developments in Antimalarial Drug Discovery. Joshi, A. A.; Viswanathan, C. L. // Anti-Infective Agents in Medicinal Chemistry;2006, Vol. 5 Issue 1, p105 

    Malaria with 1 million deaths and about 500 million new cases reported annually is a challenge to drug therapy and discovery. Drug resistance accompanied by lack of progress in the development of vaccines or resistant reversal agents has further aggravated the situation. In this scenario,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics